Susquehanna International Group, LLP Pro Phase Labs, Inc. Transaction History
Susquehanna International Group, LLP
- $527 Billion
- Q2 2024
A detailed history of Susquehanna International Group, LLP transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 62,478 shares of PRPH stock, worth $141,825. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,478
Previous 54,648
14.33%
Holding current value
$141,825
Previous $353,000
26.06%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding PRPH
# of Institutions
30Shares Held
1.67MCall Options Held
500Put Options Held
6K-
Vanguard Group Inc Valley Forge, PA656KShares$1.49 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny221KShares$500,5570.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL151KShares$343,6140.0% of portfolio
-
Geode Capital Management, LLC Boston, MA147KShares$334,0190.0% of portfolio
-
Perritt Capital Management Inc Chicago, IL85.5KShares$194,0850.21% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $36.4M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...